➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Merck
Dow
Johnson and Johnson

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Belzutifan - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for belzutifan and what is the scope of patent protection?

Belzutifan is the generic ingredient in one branded drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Belzutifan has fifty-one patent family members in twenty-seven countries.

One supplier is listed for this compound.

Summary for belzutifan
International Patents:51
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 12
Clinical Trials: 7
Patent Applications: 43
What excipients (inactive ingredients) are in belzutifan?belzutifan excipients list
DailyMed Link:belzutifan at DailyMed
Recent Clinical Trials for belzutifan

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 2
Merck Sharp & Dohme Corp.Phase 1
Eisai Inc.Phase 3

See all belzutifan clinical trials

US Patents and Regulatory Information for belzutifan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme WELIREG belzutifan TABLET;ORAL 215383-001 Aug 13, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Merck Sharp Dohme WELIREG belzutifan TABLET;ORAL 215383-001 Aug 13, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
Merck Sharp Dohme WELIREG belzutifan TABLET;ORAL 215383-001 Aug 13, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Merck Sharp Dohme WELIREG belzutifan TABLET;ORAL 215383-001 Aug 13, 2021 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Merck
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.